Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03751553
Other study ID # obstetrical gel
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date December 30, 2018
Est. completion date October 15, 2021

Study information

Verified date December 2021
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of our study is to investigate whether the use of obstetric gel shortens the first and second stage of labor and exerts a protective effect on the lower genital tract in women undergoing a Vaginal Birth After Cesarean (VBAC).


Description:

Recent literature shows that birth injury is associated with postpartum pelvic floor dysfunction (pelvic organ prolapse and fecal and urinary incontinence). Prolonged labor, namely during the 2nd stage, is one of the main obstetric risk factors responsible for anal sphincter rupture and fecal incontinence. In addition, it is associated with increased maternal and neonatal morbidities including increased risk of lower genital tract lacerations. In an effort to shorten labor and decrease lower genital tract trauma many techniques have been investigated.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date October 15, 2021
Est. primary completion date September 15, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - • Age between 18 and 40 years - Women who have had only one prior cesarean birth with no previous vaginal delivery, are eligible for VBAC and plan to attempt a VBAC after counseling. - Singleton baby in vertex presentation - Low-risk pregnancy at term (37-41 weeks of gestation) - Estimated birth weight between 2000 g and 4500 g (clinically or by sonography) - Signed written informed consent Exclusion Criteria: - • Contraindications for vaginal delivery (placenta previa, active herpes infection, etc…) - Suspected amniotic infection (fever, foul-smelling discharge, fetal tachycardia, abdominal pain) - A non-reassuring fetal heart tracing - Prolonged rupture of the membranes (24 hours) - Suspected major fetal malformations - Suspected cephalopelvic disproportion

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
obsteric gel(k-Y jelly)
A sterile obstetric gel( K-Y Jelly 82GM; manufactured by Johnson& Johnson) will be used for this trial. The obstetric gel is a birth gel with no pharmacologic effects that have purely physical activity. Starting with the first vaginal examination the obstetric gel will be used. After each vaginal examination, 3-5 mL of obstetric gel will be introduced into the vaginal birth canal in the area in front of the child manually or using the sterile obstetric gel applicator without any manipulation or massage.

Locations

Country Name City State
Egypt Ahmed Ashour Giza

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary length of the second stage of labor the length of the second stage of labor starting from full cervical dilatation till delivery of the fetus will be recorded. 1 hour
See also
  Status Clinical Trial Phase
Completed NCT05251610 - Does Oral Propranolol Accelerate Labor Induction/Augmentation With Oxytocin in Nulliparous Women in Abakaliki? N/A
Completed NCT04321642 - The Effect of Entonox on Stages of Labor in Nulliparous Women N/A
Completed NCT05676879 - Ice Massage Applied to SP6 Point at Labor N/A
Completed NCT04177888 - Effect of Hot Pack on Labor Pain, Duration of Labor, and Satisfaction of Primigravidae Women in Saudi Arabia N/A
Completed NCT06297031 - Heat Application to the Sacral Region and Pain Level During the First Stage of Labor N/A